NMR spectroscopic study of the inclusion complex of desloratadine with β-cyclodextrin in solution

  • Syed Mashhood Ali
  • Santosh Kumar Upadhyay
  • Arti Maheshwari
Original Article


Desloratadine (DES) is an antihistamine used in the treatment of allergies and chronic urticaria. 1H NMR spectroscopic study of varying ratios of DES and β-Cyclodextrin (β-CD) in D2O suggests the formation of a 1:1 inclusion complex formed by the penetration of Cl-substituted aromatic ring into the β-CD cavity. The stoichiometry and binding constant of the complex were determined by Scott’s method.


Desloratadine β-Cyclodextrin Inclusion complex NMR spectroscopy ROESY COSY 



We are grateful to the Prof. James M. Coxon, Dr. Axel T. Neffe and his team, University of Canterbury, Christchurch, New Zealand, for help in obtaining some of the NMR data. We are also grateful to Morpen Laboratories Ltd., India, for providing pure sample of desloratadine.


  1. 1.
    Simons, F.E., Prenner, B.M., Finn, Jr. A., Desloratadine study group: Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J. Clin. Immunol. 111, 617–622 (2003)Google Scholar
  2. 2.
    Wang, Y.H., Tache, Y., Harris, A.G., Kreutner, W., Daly, A.F., Wei, J.Y.: Desloratadine prevents compound 48/80-induced mast cell degranulation: Visualization using a vital fluorescent dye technique. Allergy 60, 117–124 (2005)CrossRefGoogle Scholar
  3. 3.
    Henz, B.M.: The pharmacologic profile of desloratadine: A review. Allergy, 56, 7–13 (2001)CrossRefGoogle Scholar
  4. 4.
    Esclusa-Diaz, M.T., Gayo-Otero, M., Perez-Marcos, M.B., Villa-Jato, J.L.: Preparation and evolution of ketoconazole-β-cyclodextrin multicomponent complexes. Int. J. Pharm. 142, 183–187 (1996)CrossRefGoogle Scholar
  5. 5.
    Obaidat, A.A., Matalqah, S.M., Najib, N.M.: Improvement and characterization of the in vitro dissolution behavior of sulindac by complexation with β-cyclodextrin. Acta Pharm. 52, 9–18 (2002)Google Scholar
  6. 6.
    Torres-Labandeira, J.J., Blanco-Mendez, J., Villa-Jato, J.L.: Biopharmaceutical stability of the glibornuride/β-cyclodextrin inclusion complex after one year of storage. STP Pharm. Sci. 4, 235–239 (1994)Google Scholar
  7. 7.
    Szejtli, J.: Medicinal applications of cyclodextrins. Med. Res. Rev. 14, 353–386 (1994)CrossRefGoogle Scholar
  8. 8.
    Bender, M.L., Komiyama M.: Cyclodextrin Chemistry, pp. 1. Springer Verlag, New York (1978)Google Scholar
  9. 9.
    Li, S., Purdy, W.C.: Cyclodextrin and their applications in analytical chemistry. Chem. Rev. 92, 1457 (1992)CrossRefGoogle Scholar
  10. 10.
    Schneider, H.J., Hacket, F., Rudiger, V., Ikeda, H.: NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 98, 1755–1785 (1998) (and references cited therein)CrossRefGoogle Scholar
  11. 11.
    Neuhaus, D., Williamson M.: The Nuclear Overhauser Effect in Structural and Conformational Analysis, VCH Publishers, New York (1989)Google Scholar
  12. 12.
    Estrada, E., Perdomo-Lo′pez, I., Torres-Labandeira, J.J.: Molecular modeling (MM2 and PM3) and experimental (NMR and thermal analysis) studies on the inclusion complex of salbutamol and β-cyclodextrin. J. Org. Chem. 65, 8510–8517 (2000)CrossRefGoogle Scholar
  13. 13.
    Scott, R.L.: Some comments on the Benesi-Hildebrand equation. Recl. Trav. Chim Pays-Bas 75, 787–789 (1956)Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Syed Mashhood Ali
    • 1
  • Santosh Kumar Upadhyay
    • 1
  • Arti Maheshwari
    • 1
  1. 1.Department of ChemistryAligarh Muslim UniversityAligarhIndia

Personalised recommendations